VAXART, INC. (VXRT)
Vaxart Expands Intellectual Property Portfolio with European Patent Protecting Proprietary Norovirus Vaccine Technology
Vaxart Expands Intellectual Property Portfolio with European Patent Protecting Proprietary Norovirus Vaccine Technology
📈 **POSITIVE** • Low confidence analysis (46%) • Strong positive clinical catalyst • Significant growth potential **Sentiment:** Positive (76%) **Content type:** Clinical